PDT Partners LLC acquired a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 90,507 shares of the company’s stock, valued at approximately $2,155,000.
A number of other institutional investors have also made changes to their positions in the business. Summit Securities Group LLC acquired a new position in Alignment Healthcare during the fourth quarter worth $26,000. Versant Capital Management Inc increased its stake in Alignment Healthcare by 463.3% in the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after buying an additional 1,135 shares during the last quarter. Parallel Advisors LLC increased its stake in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after buying an additional 773 shares during the last quarter. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the 3rd quarter worth about $33,000. Finally, Signature Equity Partners LLC bought a new stake in Alignment Healthcare during the 1st quarter worth about $46,000. Institutional investors own 86.19% of the company’s stock.
Insider Buying and Selling at Alignment Healthcare
In other Alignment Healthcare news, insider Hyong Kim sold 35,951 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider owned 331,750 shares of the company’s stock, valued at $6,588,555. This trade represents a 9.78% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Mark D. Kent acquired 14,848 shares of Alignment Healthcare stock in a transaction on Tuesday, June 2nd. The shares were bought at an average cost of $13.31 per share, with a total value of $197,626.88. Following the completion of the transaction, the insider owned 14,848 shares of the company’s stock, valued at approximately $197,626.88. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have sold 1,009,951 shares of company stock worth $18,597,287. 5.20% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Report on Alignment Healthcare
Key Headlines Impacting Alignment Healthcare
Here are the key news stories impacting Alignment Healthcare this week:
- Neutral Sentiment: An AAII report discussed why Alignment Healthcare stock had risen, but the available headline provides no specific new fundamental catalyst, such as improved earnings guidance or a business announcement. Why Alignment Healthcare Stock Is Up
- Neutral Sentiment: Reported August short-interest data showed zero shares and a zero-day days-to-cover ratio, an internally inconsistent result that is unlikely to provide a meaningful signal for ALHC investors. Alignment Healthcare Short Interest Report
- Negative Sentiment: Kaplan Fox announced multiple investigations into Alignment Healthcare, its officers and directors, and potential violations of federal securities laws. The firm is seeking investors who suffered losses or have relevant information, raising the possibility of future shareholder claims. These are investigations and do not establish wrongdoing. Kaplan Fox Investigation
- Negative Sentiment: Lowey Dannenberg separately said it is investigating potential federal securities-law violations involving ALHC. The second law-firm inquiry reinforces near-term litigation uncertainty and could weigh on investor sentiment. Lowey Dannenberg Investigation
- Negative Sentiment: Kaplan Fox also urged Alignment Healthcare investors to contact the firm regarding a possible securities claim, repeating the investigation-related overhang across several releases. Kaplan Fox Possible Securities Claim
Alignment Healthcare Price Performance
NASDAQ:ALHC opened at $13.90 on Thursday. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. The stock’s 50 day moving average price is $18.42 and its two-hundred day moving average price is $18.63. The firm has a market capitalization of $2.88 billion, a price-to-earnings ratio of 73.16 and a beta of 1.10. Alignment Healthcare, Inc. has a 12-month low of $12.70 and a 12-month high of $25.12.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The firm’s revenue for the quarter was up 31.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.07 EPS. On average, analysts anticipate that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current year.
Alignment Healthcare Profile
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Read More
- Five stocks we like better than Alignment Healthcare
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report).
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
